Agios Pharmaceuticals, Inc. (AGIO)
29.25
+0.67
(+2.34%)
USD |
NASDAQ |
Feb 20, 16:00
29.28
+0.03
(+0.10%)
After-Hours: 20:00
Agios Pharmaceuticals SG&A Expense (Quarterly) : 51.61M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Dynavax Technologies Corp. (DELISTED) | 40.09M |
| Gilead Sciences, Inc. | 1.794B |
| CorMedix, Inc. | 36.64M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Enanta Pharmaceuticals, Inc. | 9.009M |